Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today.
Seres Therapeutics Inc. (MCRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 90,535.95 | $1,504,707 | +78% | 0% |
| 2. | Lion Point Didric Cederholm | 17,038.05 | $283,172 | 1.48% | |
| 3. | 12,430 | $206,587 | +31% | 0% | |
| 4. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 5,035 | $83,681 | -77% | 0% |
| 5. | Engineers Gate Manager Greg Eisner | 4,249.3 | $70,623 | -19% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | Large Shareholder | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | Large Shareholder | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.81 | 3,338 | 97,536 | 2025-02-18 | Filing | ||
| $0.81 | 3,953 | 84,443 | 2025-02-18 | Filing | ||
| $0.81 | 12,726 | 192,039 | 2025-02-18 | Filing | ||
| $0.81 | 4,300 | 142,456 | 2025-02-18 | Filing | ||
| $0.81 | 4,416 | 39,875 | 2025-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 750 | $10,502 | 0% | |
| 2. | 574.75 | $8,048 | 0% | |
| 3. | 10.2 | $138 | 0% | |
| 4. | 8.75 | $123 | 0% | |
| 5. | 1,000 | $14 | 0% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bella, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2022 Earnings Call Transcript
Operator: Thank you for holding, and welcome everyone, to the Seres Therapeutics Fourth Quarter 2022 Conference Call. . Thank you. I will now turn the call over to Dr.
Billionaire Hedge Funds
